Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
Status:
Withdrawn
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
Closed-loop strategy is composed of three components: glucose sensor to read glucose levels,
insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required
insulin dosages based on the sensor's readings.
The main objective of this project is to compare the efficacy of single-hormone closed-loop
strategy and sensor-augmented pump therapy to regulate glucose levels in outpatient settings
for 5 consecutive days in adults with type 1 diabetes.
The investigators hypothesized that single-hormone closed-loop strategy will increase the
time spent in the target range compared to sensor-augmented pump therapy.